Novel transdermal targeting in steroid therapy: evaluation of PK/PD profiles using an animal model of rheumatoid arthritis
Komuro, M.; Kakuo, H.; Sawada, K.; Kawaguchi, Y.
Die Pharmazie 57(2): 147
2002
ISSN/ISBN: 0031-7144 PMID: 11878193 Document Number: 550328
Document emailed within 1 workday
Related Documents
Oliver, S.J.; Brahn, E. 1996: Combination therapy in rheumatoid arthritis: the animal model perspective Journal of Rheumatology. Supplement 44: 56-60Li, J.; Li, J.; Chen, R.; Cai, G. 2015: Targeting NF-κΒ and TNF-α Activation by Electroacupuncture to Suppress Collagen-induced Rheumatoid Arthritis in Model Rats Alternative Therapies in Health and Medicine 21(4): 26-34
Mima, T.; Nakashima, Y.; Hanba, Y.; Ohya, M.; Negi, S.; Shigematsu, T. 2012: Molecular targeting therapy in rheumatoid arthritis Nihon Jinzo Gakkai Shi 54(5): 603-609
Kraus, A. 1988: Pulse steroid therapy, rheumatoid arthritis and the Journal of Rheumatology Journal of Rheumatology 15(12): 1872-1874
Abe, C.; Hirose, S. 1988: Evaluation of immunomodulators in animal experimental models of rheumatoid arthritis Ryumachi 28(6): 450-452
Boonkasemsanti, W.; Reinprayoon, D.; Pruksananonda, K.; Niruttisard, S.; Triratanachat, S.; Leepipatpaiboon, S.; Wannakrairot, P. 1996: The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users Human Reproduction 11(Suppl 2): 115-123
Goriachev, D.V.; Erdes, S.F. 2004: Markov model of decision making for basic therapy of rheumatoid arthritis: oder of monotherapy and expenses for drug therapy Terapevticheskii Arkhiv 76(5): 35-39
Schulz, L.C.; Hertrampf, B.; Ehard, H.; Giese, W.; Drommer, W. 1976: Significance of coagulation disorders and inflammatory immune reaction in an infectious model of rheumatoid arthritis. I. Systemic, shock-like coagulopathy and fibrin incorporation as indicators of rheumatoid manifestations in the erysipelas model Zeitschrift für Rheumatologie 35(9-10): 315-323
Henrard, J.C.; Bennett, P.H.; Burch, T.A. 1974: Epidemiology of rheumatoid arthritis. Evaluation of the so-called Rome and new York criteria for the diagnosis of rheumatoid arthritis in a population study Revue du Rhumatisme et des Maladies Osteo-Articulaires 41(11): 675-683
Tomiyama, H.; Takara, I.; Tokumine, J.; Sugahara, K. 2004: Sivelestat sodium hydrate was effective for ARDS in a patient suffering from chronic rheumatoid arthritis with acute exacerbation after failing to respond to high dose steroid pulse therapy Masui. Japanese Journal of Anesthesiology 53(9): 1042-1046
Park, Y.B.; Lee, S.K.; Lee, W.K.; Suh, C.H.; Lee, C.W.; Lee, C.H.; Song, C.H.; Lee, J. 1999: Lipid profiles in untreated patients with rheumatoid arthritis Journal of Rheumatology 26(8): 1701-1704
Kurowski, M.; Dunky, A. 1992: Transdermal absorption of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis patients: I. Diclofenac International Journal of Clinical Pharmacology Therapy and Toxicology 30(11): 479
Salazar, A.C.; López, E.; Vargas, R. 1980: Evaluation of nephropathies in children with rheumatoid arthritis and prolonged therapy with salicylates Boletin Medico del Hospital Infantil de Mexico 37(2): 333-343
Trink, R.F. 1984: Evaluation of the effectiveness of health resort therapy of rheumatoid arthritis patients Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 1: 40-42
Tsitlanadze, V.G.; Dzidziguri, L.M.; Tkemaladze, L.M.; Kartvelishvili, E.I.; Shakulashvili, N.A. 1981: Use of clinico-immunological indices for the evaluation of the efficacy of the basic therapy of rheumatoid arthritis Terapevticheskii Arkhiv 53(7): 72-74
Qin, W.; Ting-Wang, H.; Bin-Xie, H.; Qing-Sun, Q.; Huang, H.; Bao-Zhao, J.; Cen, H.; Xiu-Di Wu 2019: Plasma Long Non-Coding RNA Expression Profiles in Patients with Rheumatoid Arthritis Clinical Laboratory 2019(8): 10.77
Kitamura, A. 1994: Study of the effects of a new vitamin D3 derivative on type Ii collagen-induced arthritis in an experimental rat model of rheumatoid arthritis Nihon Seikeigeka Gakkai Zasshi 68(12): 1068-1080
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Cortet, B.; Flipo, R.M.; Blanckaert, F.; Duquesnoy, B.; Marchandise, X.; Delcambre, B. 1997: Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy Revue du Rhumatisme 64(7-9): 451-458
Bálint, G.; Kirwan, J.R.; Szebenyi, B.; Hench, P. 1998: 50 years of steroid treatment of rheumatoid arthritis (Philip Hench) Orvosi Hetilap 139(42): 2521-2523